Volitionrx (VNRX) Operating Expenses (2011 - 2026)

Volitionrx (VNRX) has reported Operating Expenses for 12 consecutive years, with $4.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses fell 32.07% year-over-year to $4.6 million; the trailing twelve-month figure through Jun 2026 stood at $22.3 million (down 10.23% YoY), and the FY2025 full-year result was $23.5 million, down 16.96% from the prior year.
• Operating Expenses eased to $4.6 million in Q2 2026 per VNRX's latest filing, from $5.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $9.8 million in Q2 2023 and bottomed at $4.6 million in Q2 2026.
• Historically, Operating Expenses has averaged $7.4 million across 5 years, with a median of $7.8 million in 2022.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses soared 37.36% in 2022, then tumbled 33.52% in 2024.
• Over 5 years, Operating Expenses stood at $8.1 million in 2022, then climbed by 10.51% to $9.0 million in 2023, then sank by 33.52% to $6.0 million in 2024, then decreased by 11.85% to $5.3 million in 2025, then dropped by 13.5% to $4.6 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $4.6 million, $5.3 million, and $5.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.